DePuy

Global Conventional Hip Screws (MedCore) Market Report 2022 with DePuy Synthes, Stryker, and Zimmer Biomet Dominating - ResearchAndMarkets.com

Retrieved on: 
Tuesday, December 20, 2022
Surgery, Health, Medical Devices, ASP, Growth, COVID-19, Titanium, Stryker, DePuy, Trauma, Powder metallurgy

The "Global Conventional Hip Screws Market Size, Share, & COVID-19 Impact Analysis 2022-2028 - MedCore - Includes: Titanium Conventional Hip Screws, and 1 more" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Conventional Hip Screws Market Size, Share, & COVID-19 Impact Analysis 2022-2028 - MedCore - Includes: Titanium Conventional Hip Screws, and 1 more" report has been added to ResearchAndMarkets.com's offering.
  • The full report suite on the global market for conventional hip screws includes titanium and stainless-steel screws.
  • The global conventional hip screw market increased after a down year in 2020 because of the Global COVID-19 pandemic.
  • The global conventional hip screws market has three dominant competitors: DePuy Synthes, Stryker, and Zimmer Biomet.

Attorneys at mctlaw win a legal victory for people across the country in the Pinnacle hip replacement litigation

Retrieved on: 
Wednesday, December 14, 2022
MDL, District court, Pinnacle, Multidistrict litigation, Johnson & Johnson, Federal, J&J, DePuy, Practice of law

GAINESVILLE, Fla., Dec. 14, 2022 /PRNewswire-PRWeb/ -- Attorneys at mctlaw win a legal victory for people across the country in the Pinnacle hip replacement litigation. A federal judge in the District Court of New Jersey ruled that 33 cases against Johnson & Johnson should move out of federal court and back into New Jersey state court where J&J is headquartered (Case No. 22-1320). This means people from around the country may be able to file Pinnacle hip replacement lawsuits in New Jersey for a faster and more efficient trial process.

Key Points: 
  • Attorneys at mctlaw win a legal victory for people across the country in the Pinnacle hip replacement litigation.
  • GAINESVILLE, Fla., Dec. 14, 2022 /PRNewswire-PRWeb/ -- Attorneys at mctlaw win a legal victory for people across the country in the Pinnacle hip replacement litigation.
  • This means people from around the country may be able to file Pinnacle hip replacement lawsuits in New Jersey for a faster and more efficient trial process.
  • The legal team at mctlaw is licensed to practice law in state, federal, district, and circuit courts across the country.

Global Orthopedic Prosthetics Market Report 2022 to 2031 - Featuring Blatchford, Zimmer Biomet, DePuy Synthes and Stryker Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, November 2, 2022
Biotechnology, Health, Surgery, Medical Devices, PMA, Growth, Shoulder, 3D, Amputation, Rancho Los Amigos National Rehabilitation Center, Injury, Hospital, Ascending limb of loop of Henle, Disease, III, Safety, Technology, Hand, Food, Trauma, FDA, DePuy, Elbow, Accident, Food and Drug Administration Amendments Act of 2007, Dentistry, Medical device

The main product types of orthopedic prosthetics are upper extremity prosthetics, lower extremity prosthetics, sockets, and other products.

Key Points: 
  • The main product types of orthopedic prosthetics are upper extremity prosthetics, lower extremity prosthetics, sockets, and other products.
  • The technologies involved are conventional orthopedic prosthetics, electric-powered orthopedic prosthetics, and hybrid orthopedic prosthetics.
  • Therefore, driving the demand for orthopedic prosthetics, thus growth in the orthopedic prosthetics market.
  • The companies in the orthopedic prosthetics market are witnessing the emergence of 3D printed orthopedic prosthetics.

Profound Medical Announces Changes to its Commercial Organization to Support Continued Growth

Retrieved on: 
Thursday, September 15, 2022
Urethra, Bone, DePuy, Industry, Phrase, Hematuria, Health Canada, Louisiana State University, Technology, BS, Medical Corps (United States Army), Indian Medical Association, NASDAQ, United Nations Convention on Contracts for the International Sale of Goods, BPH, Adoption, VP, Food, AG, National Medical Products Administration, Brainlab, Company, Growth, MBA, CE, Biology, FDA, Humanitarian Device Exemption, Uterine fibroid, Medtronic, American Medical Association, GLOBE, TSX, Biological engineering, Prostate, MRI, Rectum, Regulation of tobacco by the U.S. Food and Drug Administration, Risk, Hyperthermia, Prostate cancer, Covidien, Pharmaceutical industry, IMRIS, Profound Pharma, Boston Scientific

At the same time, we are excited that he is leaving our commercial organization in such good hands.

Key Points: 
  • At the same time, we are excited that he is leaving our commercial organization in such good hands.
  • Ms. Goodman brings over 17 years of medical device sales experience, most recently serving as Profounds VP, U.S.
  • Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue.
  • Profound is commercializing TULSA-PRO, a technology that combines real-time MRI, robotically-driven transurethral ultrasound and closed-loop temperature feedback control.

Dr Kingsley R Chin steps down as CEO of NanoFuse Biologics LLC after merger with NANISX LLC

Retrieved on: 
Friday, September 9, 2022
Health care, Johnson & Johnson, CEO, Technology, EBITDA, DePuy, DBM, Solution, Orthopedic surgery, Ambulatory Surgery Center Association, 3D ultrasound, Spine, Phosphate, IPO, IPM, Synthetic, CFO, Interventional pain management, FDA, LLC, Elective surgery, ASC, Acquisition, Ceramic, Pharmaceutical industry, Calcium, Neurosurgery, Sodium

MALDEN, Mass., Sept. 9, 2022 /PRNewswire-PRWeb/ -- NanoFUSE Biologics is the world's only FDA-approved synthetic fiber-based bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation, promoting fusion and bone healing. NanoFUSE, when combined with an aqueous body fluid, forms a 3D ultra porous calcium hydroxyapatite layer for bone formation in as early as 24 hours. This reaction leads to the immediate release of Calcium, Sodium, Silica and Phosphate ions and the angiogenic/osteogenic response. Healthcare investment firm focused on ambulatory surgery center (ASC) spine surgery, KICVentures Group, owns NanoFuse Biologics LLC, Inspan LLC and Sacrix LLC and merged its holdings into NANISX LLC as of August 15th, 2022.

Key Points: 
  • NanoFUSE Biologics is the world's only FDA-approved fiber-based synthetic bioactive glass combined with demineralized bone matrix (DBM) for regenerative bone formation, promoting fusion and bone healing.
  • NanoFUSE Biologics LLC merged with NANISX LLC on August 15th, 2022 to offer a combined technology platform to Ambulatory Surgery Centers (ASC).
  • Healthcare investment firm focused on ambulatory surgery center (ASC) spine surgery, KICVentures Group, owns NanoFuse Biologics LLC, Inspan LLC and Sacrix LLC and merged its holdings into NANISX LLC as of August 15th, 2022.
  • NanoFUSE Biologics LLC is privately owned by the KICVentures Group and has a proprietary fiber-based synthetic bioactive glass.

Medical Technology Specialist Joins CD&R's Healthcare Team

Retrieved on: 
Tuesday, May 3, 2022
Ben-Gurion University of the Negev, Investment, CD, Culture, NEW, Johnson & Johnson, Harvard Business School, Clayton, Dubilier & Rice, Company, Electrophysiology, Global Network for Advanced Management, CD&R, Leadership, DePuy, Elective surgery, R, Spine, Cardiology, Dubilier, Multimedia, Pharmaceutical industry, Medicine

NEW YORK, May 3, 2022 /PRNewswire/ -- Clayton, Dubilier & Rice announced Nadav Tomer, a medical technology specialist, has been named an Operating Advisor to CD&R funds. Mr. Tomer will work with CD&R's healthcare team to help source new investments and advise the funds' healthcare businesses.

Key Points: 
  • Mr. Tomer will work with CD&R's healthcare team to help source new investments and advise the funds' healthcare businesses.
  • "Nadav brings a strong track record of execution and deep experience leading global businesses in the medical technology field across a range of therapeutic areas and disciplines," said CD&R Partner Derek Strum.
  • "We believe he will be highly valuable in creating differentiated angles and enhancing our ability to underwrite high conviction, execution-based investment cases as we look to expand our investments in medical technology."
  • "I look forward to working with the talented CD&R team of investment and operating professionals and contributing to the continued success of the CD&R funds and their portfolio companies in the medical technology sector."

Business Tycoon Shifts Focus to Improve Healthcare

Retrieved on: 
Tuesday, March 8, 2022
Leadership, Medical device, Investment, Surgeon, Industry, Medtronic, Woman, Ghost, Growth, Ghost (production team), Bausch & Lomb, CEO, XR, DePuy, History, XX, MD, Virtual reality, VR, Management

Recognized business leader, Timothy Yocum has been tapped as Chief Executive Officer with a mandate for growth focusing on leading-edge technologies, like VR, XR, and simulation-based surgical training programs.

Key Points: 
  • Recognized business leader, Timothy Yocum has been tapped as Chief Executive Officer with a mandate for growth focusing on leading-edge technologies, like VR, XR, and simulation-based surgical training programs.
  • Current CEO, Laura Schulz will remain a critical member of the executive team, assuming the role of Chief Operating Officer.
  • "The Ghost team has a 25-year history of leading innovation in the medical industry, making 3-D medical animations indispensable for medical device giants like Medtronic, Smith+Nephew, Depuy, and Bausch + Lomb.
  • Her vision for the Ghost Productions team and the medical industry landed her on Healthcare Technology Report's list of Top 25 Women Leaders In Medical Devices .

Cloud-Managed Enterprise Wireless LAN Services Revenues Grew 37% Y/Y, According to 650 Group

Retrieved on: 
Wednesday, March 2, 2022
Cloud, Research, Juniper, DePuy, Extreme Networks, Juniper Networks, Radio, Technology, Social networking service, Aruba, Controller, Cloud management, Cisco Systems, Group, CommScope, Y/Y, Enterprise, Acceleration, GLOBE, Network equipment, WLAN, Ubiquiti

"Cloud-Managed WLAN Services are growing faster than hardware sales as a larger group of vendors embrace this exciting technology.

Key Points: 
  • "Cloud-Managed WLAN Services are growing faster than hardware sales as a larger group of vendors embrace this exciting technology.
  • 650 Groups quarterly Cloud-Managed Services publication shows that some leading vendors: Commscope, Extreme Networks, HPE Aruba, and Juniper Networks are growing more rapidly than the overall Cloud-Managed WLAN services market," said Chris DePuy, Founder and Technology Analyst at 650 Group.
  • The Enterprise Wireless LAN Quarterly Report offers a market assessment of vendor performance and market share, and forecasts.
  • The Cloud-Managed Network Services Report entails Cloud-Managed Services Cloud-Managed Network Products for Enterprise WLAN and Campus Ethernet Switching.

Hip Innovation Technology Strengthens Senior Leadership Team

Retrieved on: 
Wednesday, February 16, 2022
Trial of the century, HRS, Patient, Surgeon, Technology, LLC, Reverse, Quality of life, Regulation, Motion, Risk, COO, Company, Osteolysis, Entrepreneurship, Quality assurance, Engineering, CSO, Orthopedic surgery, American Knees, R, University, Private Securities Litigation Reform Act, Rotation, Dislocation, Macdonald, Hip, Intention, BOCA, Global Health Innovative Technology Fund, HIT, MD, DePuy, FDA, Partnership, Professor, Spine, Growth, Research, News, Industry, Pharmaceutical industry, Medical device

Dr. MacDonald is an internationally recognized hip and knee replacement thought leader.

Key Points: 
  • Dr. MacDonald is an internationally recognized hip and knee replacement thought leader.
  • He has received over 25 research grants for hip and knee replacement projects totaling over 5 million dollars.
  • He has published over 200 research papers and book chapters and has lectured at over 250 national and international meetings.
  • "Each step builds on previous successes, culminating in a pivotal FDA IDE clinical study planned for initiation in 2022.

POPE MCGLAMRY, P.C. FILES LAWSUIT AGAINST EXACTECH FOR DEFECTIVE HIP IMPLANT

Retrieved on: 
Tuesday, February 15, 2022
Bone loss, UHMWPE, Risk, Osteolysis, Biotechnology, Plaintiff, Microport, Ankle, Leadership, Knee, Pope, Stryker, Pain, Novation, DePuy, Failure, Stiffness, District court, Connexion, Medical device

ATLANTA, Feb. 15, 2022 /PRNewswire/ --On February 11, 2022, Pope McGlamry filed a federal lawsuit against orthopedic device manufacturer, Exactech, Inc.

Key Points: 
  • ATLANTA, Feb. 15, 2022 /PRNewswire/ --On February 11, 2022, Pope McGlamry filed a federal lawsuit against orthopedic device manufacturer, Exactech, Inc.
  • A hip liner is the component inserted into the artificial hip socket or cup that interfaces with the femoral head or ball.
  • On February 11, 2022, Pope McGlamry filed a federal lawsuit against orthopedic device manufacturer, Exactech, Inc.
  • The Exactech hip liner at issue is the Connexion GXL Liner, which is made of irradiated ultra-high molecular weight polyethylene (UHMWPE).